Skip to content
Optellum
  • About us
    • Vision
    • Team
    • Advisors
    • Careers
  • Products & solutions
    • Incidental management
    • Lung Cancer Prediction AI
  • Resources
    • Case Studies
    • Clinical Validation
    • Reimbursement
    • Customer Support
  • News & Events
    • In the Media
  • Contact
    • General inquiries
    • Newsletter
    • Contact sales
  • Toggle website search
Menu Close
  • About us
    • Vision
    • Team
    • Advisors
    • Careers
  • Products & solutions
    • Incidental management
    • Lung Cancer Prediction AI
  • Resources
    • Case Studies
    • Clinical Validation
    • Reimbursement
    • Customer Support
  • News & Events
    • In the Media
  • Contact
    • General inquiries
    • Newsletter
    • Contact sales
  • Toggle website search

News & Events

Health Tech Digital: Optellum announces strategic collaboration with the Lung Cancer Initiative at Johnson & Johnson applying AI to transform early lung cancer treatment

  • Post author:Rhiannon Lassiter
  • Post published:August 20, 2021
  • Post category:Media

Health Tech Digital

Read more articles

Previous PostEmintera: Optellum announces strategic collaboration with Johnson & Johnson’s Lung Cancer Initiative to apply AI to transform early lung cancer treatment
Next PostEIT Health-supported Optellum partners with J&J

You Might Also Like

Read more about the article Lung cancer detection AI gets a boost from J&J  (subscription required)

Lung cancer detection AI gets a boost from J&J (subscription required)

August 19, 2021
Read more about the article GE, Optellum Join Hands To Boost Advance Lung Cancer Diagnosis With AI

GE, Optellum Join Hands To Boost Advance Lung Cancer Diagnosis With AI

November 26, 2021
Read more about the article 150 most promising digital health companies of 2022, according to CB Insights

150 most promising digital health companies of 2022, according to CB Insights

December 7, 2022
  • Back to News & Events

Recent Posts

  • Optellum’s Clinical Partners Present at ATS International Conference 2023
  • Optellum technology can help to determine more cost-effective intervals for lung cancer screening
  • AtlantiCare First in Northeast to Deploy Optellum AI Alongside Robotics for Early Lung Cancer Diagnosis and Treatment
  • Jason Pesterfield, Optellum CEO, appears on Houston Innovators podcast
  • 150 most promising digital health companies of 2022, according to CB Insights

Our Mission

Optellum was founded so that every lung disease patient is diagnosed and treated at the earliest possible stage, and cured.  Our vision is to redefine early intervention of diseases like lung cancer, by enabling every clinician, in every hospital, to make the right decisions and give their patients the best chance to fight back.

Optellum Ltd.

  • Oxford Centre for Innovation
    Oxford, OX1 1BY
    United Kingdom
  • info@optellum.comOpens in your application

Optellum Inc.

  • TMC Innovation Institute
    2450 Holcombe Blvd, Suite X
    Houston, TX 77021
    United States

Pages

  • About us
    • Vision
    • Team
    • Advisors
    • Careers
  • Products & solutions
    • Incidental management
    • Lung Cancer Prediction AI
  • Resources
    • Case Studies
    • Clinical Validation
    • Reimbursement
    • Customer Support
  • News & Events
    • In the Media
  • Contact
    • General inquiries
    • Newsletter
    • Contact sales

Follow Us

  • Opens in a new tab
  • Opens in a new tab

Certifications

Copyright 2023 - Optellum Ltd | Privacy Policy
Manage Cookie Consent
We use cookies to optimize our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}